Opening Asia for Russia

Chinese authorities have approved the use of the drug Sinopharm for children from three years

19.08.2021 39 просмотров

Vaccinations for minors under the age of 17 will be given in an emergency.


Chinese authorities will begin vaccination against a new type of coronavirus in children aged three years with a drug from the national pharmaceutical company Sinopharm, created in a laboratory in Wuhan. This is stated in a statement published on Wednesday on the website of the vaccine manufacturer.

It was in Wuhan at the end of 2019 that the world's first outbreak of a disease caused by a new coronavirus was detected. As specified in the message, vaccinations for minors under the age of 17 will be done in emergency cases. The corresponding decision was made by the Chinese epidemiological control authorities.

According to the management of Sinopharm, the effectiveness of children's vaccination with this drug is 96.1%. “It is completely safe, only a mild negative reaction is possible, and no complications have been recorded,” the statement emphasizes.

Sinopharm has created two inactivated coronavirus vaccines (one in the capital’s laboratory, the other in Wuhan). In mid-July, the Pengpai information portal reported that the Chinese authorities approved the use of the Beijing drug for people aged 3 to 17 years. Thus, now both Sinopharm products can be officially used in China among minors.

Новости партнёров